Massimo Cristofanilli

Northwestern University Feinberg School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2022

Collaborators (6)

Fabio Puglisi

Head of the Unit of Medical Oncology and Cancer Prevention

ITALY

View details

Carolina Reduzzi

Assistant Professor

Weill Cornell Medicine

UNITED STATES

View details

Catherine Alix-Panabières

Associate Professor, Director

University Hospital of Montpellier

FRANCE

View details

Michail Ignatiadis

BELGIUM

View details

Xia Liu

UNITED STATES

View details

lei li

Assistant Professor

University of Georgia

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Massimo Cristofanilli

Research Interests

Explore related searches

Contact this professor

Articles (12)

Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i): Mechanisms of resistance and where to find them

Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2− Breast Cancer

Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis

Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes

Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profiling

MGAT1-Guided complex N-Glycans on CD73 regulate immune evasion in triple-negative breast cancer

Mapping breast cancer therapy with circulating tumor cells: The expert perspective

Prospective Evaluation of Circulating Tumor DNA Using Next-generation Sequencing as a Biomarker During Neoadjuvant Chemotherapy in Localized Pancreatic Cancer

Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast Cancer

TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancer

ICAM-1-suPAR-CD11b Axis Is a Novel Therapeutic Target for Metastatic Triple-Negative Breast Cancer

Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation

Collaborators (6)

Fabio Puglisi

Carolina Reduzzi

Catherine Alix-Panabières

Michail Ignatiadis

Xia Liu

lei li

Make your next move.